That is such lazy analysis work in that report.
RANT
These guys are supposed to price value. All they did was price dilution. Yet they have no facts to go on regarding dilution timing, predicted amount, nor at what price, nor any suggestes inflection point. In fact management DOES NOT have to dilute at all. It could fund the new drug from revenue (upfront deal money). This is even shown in the business.
- Forums
- ASX - By Stock
- KZA
- KZA Media Thread
KZA Media Thread, page-1422
-
-
- There are more pages in this discussion • 645 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)